Risk factors for surgical site infection after craniotomy: a prospective cohort study by Jiménez Martínez, Emilio et al.
RESEARCH Open Access
Risk factors for surgical site infection after
craniotomy: a prospective cohort study
Emilio Jiménez-Martínez1†, Guillermo Cuervo1*†, Ana Hornero1, Pilar Ciercoles1, Andres Gabarrós2,
Carmen Cabellos1, Ivan Pelegrin3, Dolores García-Somoza4, Jordi Adamuz5,6, Jordi Carratalà1,6 and Miquel Pujol1
Abstract
Background: Although surgical site infection after craniotomy (SSI-CRAN) is a serious complication, risk factors for
its development have not been well defined. We aim to identify the risk factors for developing SSI-CRAN in a large
prospective cohort of adult patients undergoing craniotomy.
Methods: A series of consecutive patients who underwent craniotomy at a university hospital from January 2013 to
December 2015 were prospectively assessed. Demographic, epidemiological, surgical, clinical and microbiological
data were collected. Patients were followed up in an active post-discharge surveillance programm e for up to one
year after surgery. Multivariate analysis was carried out to identify independent risk factors for SSI-CRAN.
Results: Among the 595 patients who underwent craniotomy, 91 (15.3%) episodes of SSI-CRAN were recorded, 67
(73.6%) of which were organ/space. Baseline demographic characteristics were similar among patients who developed
SSI-CRAN and those who did not. The most frequent causative Gram-positive organisms were Cutibacterium acnes (23.1%)
and Staphylococcus epidermidis (23.1%), whereas Enterobacter cloacae (12.1%) was the most commonly isolated Gram-
negative agent. In the univariate analysis the factors associated with SSI-CRAN were ASA score > 2 (48.4% vs. 35.5% in
SSI-CRAN and no SSI-CRAN respectively, p = 0.025), extrinsic tumour (28.6% vs. 19.2%, p = 0.05), and re-intervention (4.4%
vs. 1.4%, p = < 0.001). In the multivariate analysis, ASA score > 2 (AOR: 2.26, 95% CI: 1.32–3.87; p = .003) and re-intervention
(OR: 8.93, 95% CI: 5.33–14.96; p < 0.001) were the only factors independently associated with SSI-CRAN.
Conclusion: The risk factors and causative agents of SSI-CRAN identified in this study should be considered in the design
of preventive strategies aimed to reduce the incidence of this serious complication.
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Background
Craniotomy is a surgical procedure in which part of the
skull bone is removed to expose the brain and the central
nervous system. The bone flap is temporarily separated
and is returned to its previous location at the end of
surgery in order to protect the brain and its structures. In
many cases, metal plates are used to hold the bone flap in
place. The incidence of surgical site infection after craniot-
omy (SSI-CRAN) ranges from 2.2 to 19.8% [1–6]. SSI-
CRAN has potentially devastating consequences: it is
associated with significant morbidity and requires complex
treatment that often involves the removal of the bone flap
and long-term antibiotic therapy [5, 7]. Indeed, SSI-CRAN
is associated with longer hospital stay, significant health
care costs, and non-negligible mortality [1].
The risk factors for SSI-CRAN are still poorly under-
stood. Previous studies have identified several associated
factors, including age, gender, duration of operation, sur-
gical site, reason for surgery, emergency procedure, anti-
biotic prophylaxis, steroid use, cerebrospinal fluid (CSF)
drainage, and American Society of Anesthesiologists
(ASA) score [2–12]. However, those studies presented
certain limitations, such as small sample sizes, substan-
tial variations in the inclusion criteria, and marked dif-
ferences in patients’ baseline characteristics. Therefore,
more evidence is still needed to define more precisely
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the risk factors for developing SSI-CRAN. An accurate
identification of the risk factors and main causative
pathogens of SSI-CRAN might be helpful in the design
of future preventive strategies.
In this study, we aimed to identify the aetiology and
risk factors of SSI-CRAN in a large contemporary cohort
of consecutive adult patients undergoing craniotomy in
a university hospital.
Methods
Study design, setting and patients
A prospective cohort study was carried out in a 700-bed
university hospital for adults in Barcelona, Spain, which
admits average of 1300 patients to the neurosurgery
ward each year. All adult patients (> 18 years old) who
underwent a craniotomy (e.g., tumour resection, epi-
lepsy, vascular abnormalities, trauma, etc.) from 1st
January 2013 to 31th December 2015 were included. Pa-
tients were prospectively followed up by members of the
hospital infection control team. The staff performing
surveillance had received training in surveillance meth-
odology to ensure the collection of homogeneous and
accurate data. Active mandatory post-discharge surveil-
lance was carried out up to 1-year post surgery applying
a multimodal approach including the following items: a)
electronic review of clinical records (primary and sec-
ondary care) integrated in the platform SAP® (Systems,
Applications & Products, Waldorff, Germany); b) check-
ing of readmissions; c) checking of emergency visits; d)
review of microbiological and radiological data within
the period of post-discharge surveillance.
All patients underwent the same protocol regarding prep-
aration for surgery, which include at least showering (with
4% clorhexidine gluconate detergent solution) on the day
before and on the morning of the operation, head included.
In the surgical area, the hair was cut with a sterile electric
clipper. Pre-operative skin preparation involved standard-
ized application of at least three swabs, soaked with
povidone-iodine solution. Antibiotic prophylaxis involved
pre-operative intravenous cefuroxime 1500mg 30–60min
prior to incision and re-administration every 3 h during the
operation. The skin was closed using a skin stapler and the
head was washed with povidone-iodine solution. Post-op-
eratively, the surgical wound was draped with a sterile im-
permeable towel for the first 24 h post-surgery. Afterwards,
a head wash was performed every 12 h with
povidone-iodine soap the first 72 h and surgical
wound-care was carried out every 24 h under strict aseptic
conditions. Povidine-iodine was used instead of 2% clorhex-
idine because of neurotoxicity [13].
At the moment of SSIs diagnosis, neurosurgeons and
infectious diseases specialists work side by side in the
management of these patients. In superficial incisional
SSIs, treatment often involves specific wound care with
silver-containing hydrofiber dressings and sometimes
additional systemic antibiotic treatment. In deep inci-
sional and organ-space SSIs, surgical re-intervention is
mostly needed, involving bone graft replacement and an
invariably systemic antibiotic treatment.
The need for informed consent and the information
sheet were waived because the follow-up of patients
undergoing craniotomy is part of the centre’s own sur-
veillance programme. Ethical standards related to ano-
nymity and data confidentiality (access to records, data
encryption, and archiving of information) were observed
throughout the research process. Patients’ confidential
information was protected in accordance with European
regulations, and the study was approved by the Clinical
Research Ethics Committee of Bellvitge University Hos-
pital (Reference number PR334/18).
Main outcome, variables, and data source
The main outcome analysed was the development of a
SSI-CRAN within one year post-surgery. The clinical char-
acteristics of patients who developed SSI-CRAN were com-
pared with those who did not. Basic demographic data
were recorded, along with the following information on pa-
tient comorbidities and surgical procedure: Charlson score,
diabetes mellitus, chronic obstructive pulmonary disease,
immunosuppression and cirrhosis; information on surgical
procedures, including ASA and National Nosocomial Infec-
tions Surveillance (NNIS) score, elective/emergency sur-
gery, reason for surgery (intrinsic tumour, extrinsic tumour,
epilepsy, vascular, traumatic or others), operative site
(supratentorial, infratentorial or retromastoid), administra-
tion of antibiotic prophylaxis according to hospital guide-
lines, duration of surgery, use of intracranial pressure (ICP)
monitors, number of surgeries, CSF leak and metal plates;
characteristics of infection (SSI-CRAN classification and
microorganisms identified); and in-hospital outcome data
(pre and post-surgery in-hospital stay).
Definitions
SSI-CRAN was defined according to Centers for Disease
Control and Prevention (CDC) criteria, as follows: a) puru-
lent drainage from a surgical incision; b) organism identifi-
cation by culture from fluid or tissue obtained aseptically;
c) incision that dehisces spontaneously or is deliberately
opened by a surgeon or physician, localized pain or tender-
ness, localized inflammation (heat, erythema and swelling),
and/or fever (> 38 °C); and evidence of abscess on images
or surgical revision. SSI-CRAN was also classified accord-
ing to CDC criteria as superficial incisional, deep incisional
or organ-space infection [14]. Post-discharge surveillance of
SSI was mandatory and consisted in the review of elec-
tronic clinical records in primary and secondary care,
checking readmissions and emergency visits, and reviewing
microbiological and radiological data.
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The reason for surgery was defined by the patient’s dis-
ease, which was divided into: a) intrinsic tumour in the par-
enchyma, b) extrinsic tumour in the structures of the
central nervous system in the skull, c) epilepsy, d) vascular
disease, e) traumatic disease and f) others. The use of ste-
roids/chemotherapy both in the last two weeks pre-surgery
and in the two weeks post-surgery was recorded.
Charlson Score was defined as a system of evaluation of
life expectancy at ten years, depending on the age at which
it is evaluated, and the comorbidities of the subject [15].
Intravenous antibiotic prophylaxis was considered adequate
when the following three factors were all met: antibiotic ad-
ministration according to local protocol, completion of the
infusion within 60min of the surgical incision, and peri-
operative antibiotic re-administered if indicated.
Microbiological studies
In most patients with suspected SSI-CRAN, microbiological
samples from wounds and/or CSF fluid or abscesses were
taken for culture. Blood cultures were also taken when indi-
cated by the attending physician. Antibiotic susceptibility
was determined using the microdilution method following
Clinical Laboratory Standard Institute (CLSI) guidelines.
The antimicrobial susceptibility of isolates was interpreted
according to current CLSI criteria [16].
Statistical methods
Quantitative variables are reported as medians and inter-
quartile range (IQR); categorical variables are reported as
absolute numbers and percentages. To detect significant
differences between groups, the chi-square test or the Fish-
er’s exact test was used for categorical variables, and the
Student t-test or Mann–Whitney U test for continuous var-
iables, as appropriate. Factors associated with SSI-CRAN
were evaluated by univariate and multivariate analysis. The
multivariate analysis included variables from the univariate
analysis with a p-value < 0.1 and other factors considered
relevant according to a literature review. The goodness of
fit of the final multivariate model was assessed by the Hos-
mer–Lemeshow test and the area under the receiver oper-
ating characteristics curve. Results of multivariate analyses
were reported as odds ratios (OR) and 95% confidence in-
tervals (CI). The statistical analysis was performed with ver-
sion 24.0 of the SPSS software package (SPSS, Chicago, IL).
Statistical significance was established at α = 0.05, and all
reported p-values are two-tailed.
This paper was written in accordance with the Add-
itional file 1: STROBE statement (https://strobe-state-
ment.org/index.php?id=available-checklists).
Results
During the study period, 595 patients who underwent cra-
niotomy were followed up. Baseline clinical characteristics
are summarized in Table 1. There were 274 male patients
(46.1%) and mean age was 52.8 years (standard deviation
[SD] = 14.4). An average of 198 interventions were per-
formed each year during the study period. The main causes
for surgical intervention were intrinsic tumour (n = 234,
39.3%), and vascular disease (n = 152, 25.5%). Supratentor-
ial region was the most common frequent surgical site
(n = 449, 75.5%). Of the 91 episodes of SSI-CRAN, 61 epi-
sodes (67%) required re-intervention.
The overall SSI-CRAN incidence at the end of follow-up
was 15.3% (n = 91). As shown in Table 2, SSI was
organ-space in 73.6% (n = 67) of patients, deep-incisional in
17.6% (n = 16) and superficial in 8.8% (n = 8). Most of the
SSI-CRAN required rehospitalization (n = 49, 53.8%). The
aetiology varied according to surgical site: overall Cutibac-
terium acnes (n = 21, 23.1%) and Staphylococcus epidermi-
dis (n = 21, 23.1%) were the most frequently isolated
Table 1 Baseline characteristics
Baseline characteristics
OVERALL (n = 595)
Male, n (%) 274 (46.1)
Mean age, years (SD) 52.8 (14.4)
> 65y, n (%) 148 (24.9)
Urgent surgery, n (%) 79 (13.3)
Reason of surgery:
Intrinsic tumour, n (%) 234 (39.3)
Extrinsic tumour, n (%) 123 (20.7)
Epilepsy, n (%) 23 (3.9)
Vascular, n (%) 152 (25.5)
Trauma, n (%) 17 (2.9)
Others, n (%) 46 (7.7)
Surgical site:
Supratentorial, n (%) 449 (75.5)
Infratentorial, n (%) 62 (10.4)
Retromastoid, n (%) 84 (14.1)
Duration of surgery, minutes (SD) 256.9 (101.5)
> P75a, n (%) 152 (25.5)
Mean hospital stay, median (range) 7 (5–14)
CHARLSON score, (range) 3 (0–13)
< 3, n (%) 292 (49.1)
3–5, n (%) 214 (36)
6–8, n (%) 69 (11.6)
> 9, n (%) 20 (3.4)
ASAb, (range) 2 (1–5)
ASA > 2, n (%) 223 (37.5)
NNISc, (range) 1 (0–2)
NNIS I-II, n (%) 441 (74.1)
a > 75 percentile of duration of surgery
bAmerican Society of Anaesthesiologists
cNational Nosocomial Infection Surveillance System
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Gram-positive microorganisms, whereas Enterobacter clo-
acae (n = 11, 12.1%) was the most prevalent Gram-negative
microorganism (Table 3). According to surgical site, C.
acnes was the most frequent aetiology in retromastoid and
supratentorial areas (33.3 and 23.8% respectively), while
methicillin-susceptible Staphylococcus aureus was the most
commonly isolated organism in infratentorial regions
(38.5%). No differences were found between aetiology and
reason of surgery.
A comparison of the study population by groups
(SSI-CRAN and non-SSI-CRAN) is shown in Table 4.
Univariate analysis of risk factors found higher ASA
scores (ASA score > 2 [48.4% vs. 35.5%, p = 0.025]), extrin-
sic tumour (28.6% vs. 19.2%, p = 0.05) and re-intervention
(4.4% vs. 1.4%, p = < 0.001) to be significantly associated
with SSI-CRAN. Interestingly, metal plates was less
frequent in SSI-CRAN group (92.3% vs. 85.7%, p = 0.06).
Conversely, no difference were found between the groups
in terms of emergency surgery (13.1% vs. 14.3%, p = 0.74),
NNIS score I-II (73.8% vs. 75.8%, p = 0.79) and inappro-
priate antibiotic prophylaxis (11.7% vs. 12.1%, p = 0.86).
The multivariate logistic regression analysis (Hosmer–
Lemeshow goodness of fit of the model: 0.713. AUC= 0.81;
95% CI, 0.77–0.86) showed that the only independent risk
factors for developing a SSI-CRAN were ASA score > 2
(AOR: 2.26, 95% CI: 1.32–3.87; p = 0.003) and
re-intervention (AOR: 8.93, 95% CI: 5.33–14.96; p < 0.001).
Discussion
This study of a large cohort of hospitalized patients
undergoing a craniotomy at a teaching hospital in Barce-
lona found that the most frequently isolated causative
agents were Gram-positive cocci and that the only risk
factors independently associated with SSI-CRAN were
ASA score > 2 and need for re-intervention.
The overall SSI-CRAN rate was 15.3%. This percentage
is higher than those reported in previous studies (a mean
rate of 6.1%) [1, 6, 8, 12, 17]. In line with other studies,
organ-space SSI-CRAN was the most prevalent surgical
site infection [3, 4]. Despite the severity of the infections,
mortality was low. On the other hand, there is a consider-
able increase in hospital days. The high rate of SSI-CRAN
found in the current study could be partly explained by
the use of different definitions and a stricter and longer
patient follow-up than in previous research [18–21]. The
CDC score is a well-established tool for the classification
of surgical site infection and provides homogeneity among
studies; however, it only includes surgical site infection
within 30 days after surgery. In contrast, our data, with a
Table 2 Characteristics of SSI-CRAN
SSI-CRAN (n = 91)
Occurrence of SSI-CRAN, days (SD) 39 (54)
Detection:
During hospital admission, n (%) 31 (34.1)
Post-discharge surveillance, n (%) 11 (12.1)
Readmission, n (%) 49 (53.8)
SSI-CRAN classification:
Superficial, n (%) 8 (8.8)
Deep incisional, n (%) 16 (17.6)
Organ-space, n (%) 67 (73.6)
Age, mean (SD) 51.4 (15.3)
Table 3 SSI-CRAN aetiology
SSI-CRAN aetiology
Supratentorial (n = 63) Infratentorial (n = 13) Retromastoid (n = 15) Overall (n = 91)
n % n % n % n %
GPCa Cutibacterium acnes 15 (23.8) 1 (7.7) 5 (33.3) 21 (23.1)
Staphylococcus epidermidis 13 (20.7) 4 (30.8) 4 (26.7) 21 (23.1)
MSSAc 11 (17.5) 5 (38.5) 2 (13.3) 18 (19.8)
MRSAd 3 (4.8) 0 – 0 – 3 (3.3)
CNSe 1 (1.6) 0 – 2 (13.3) 3 (3.3)
GNBb E.cloacae 9 (14.3) 1 (7.7) 1 (6.7) 11 (12.1)
P.aeruginosa 5 (8) 2 (15.4) 1 (6.7) 8 (8.8)
K.pneumoniae 4 (6.3) 1 (7.7) 0 – 5 (5.5)
E.coli 3 (4.8) 1 (7.7) 0 – 4 (4.4)
Polymicro (>2microorg) 1 (1.6) 0 – 1 (6.7) 2 (2.2)
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Table 4 Univariate and multivariate analysis of risk factors for treatment failure in organ-space SSI-CRAN






p-value OR 95% CI p-value
Male, n (%) 232 (46) 42 (46.2) 1 0.86 0.52–1.43 0.57
Mean age, years (SD) 53.1 (14.3) 51.4 (15.3) 0.26 0.99 0.97–1.01 0.33
> 65 years (%) 129 (25.6) 19 (20.9) 0.36
Urgent surgery, n (%) 66 (13.1) 13 (14.3) 0.74
Reason for surgery:
Intrinsic tumour, n (%) 203 (40.3) 31 (34.1) 0.29
Extrinsic tumour, n (%) 97 (19.2) 26 (28.6) 0.05 1.71 0.91–3.24 0.09
Epilepsy, n (%) 23 (4.6) 0 (0) 0.03 0 0 0.99
Vascular, n (%) 130 (25.8) 22 (24.2) 0.79
Trauma, n (%) 14 (2.8) 3 (3.3) 0.73
Others, n (%) 37 (7.3) 9 (9.9) 0.39
Surgical site:
Supratentorial, n (%) 386 (76.6) 63 (69.2) 0.15
Infratentorial, n (%) 49 (9.7) 13 (14.3) 0.19
Retromastoid, n (%) 69 (13.7) 15 (27.5) 0.51
Duration of surgery, minutes (SD) 255.2 (99.6) 265.9 (111.4) 0.65
> P75a, n (%) 124 (24.6) 28 (30.8) 0.57
Mean hospital stay, median (range) 7 (5–13) 7 (5–31) 0.59
CHARLSON, mean (SD) 3.14 (2.3) 3.03 (2.2) 0.70 0.90 0.78–1.05 0.20
< 3, n (%) 245 (48.6) 47 (51.6) 0.65
3–5, n (%) 184 (36.5) 30 (33) 0.55
6–8, n (%) 56 (11.1) 13 (14.3) 0.38
> 9, n (%) 19 (3.8) 1 (1.1) 0.34
ASAb, mean (SD) 2.3 (0.7) 2.4 (0.8) 0.08
ASA > 2, n (%) 179 (35.5) 44 (48.4) 0.025 2.26 1.32–3.87 0.003
NNISc, mean (SD) 0.9 (0.7) 1 (0.7) 0.24
NNIS I-II, n (%) 372 (73.8) 69 (75.8) 0.79
Antibiotic prophylaxis:
Appropriate, n (%) 432 (85.7) 80 (87.9) 0.74
Inappropriate, n (%) 59 (11.7) 11 (12.1) 0.86
Non registered, n (%) 13 (2.6) 0 (0) 0.23
Metal plates, n (%) 465 (92.3) 78 (85.7) 0.06 1.8 0.84–3.87 0.13
Use of steroids/chemotherapy, n (%) 369 (73.2) 70 (76.9) 0.52
Re-intervention, n (%) 97 (19.2) 61 (67) < 0.001 8.93 5.33–14.96 < 0.001
ICPd sensor, n (%) 30 (6) 6 (6.6) 0.81
CSFe leak, n (%) 7 (1.4) 4 (4.4) 0.72 0.85 0.21–3.44 0.82
Mortality 30d post surgery, n (%) 31 (6.2) 2 (2.2) 0.21
a > 75 percentile of duration of surgery
bAmerican Society of Anaesthesiologists
cNational Nosocomial Infection Surveillance System
dIntracranial pressure
eCerebrospinal fluid
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follow up of one year, found the median time for the oc-
currence of SSI-CRAN to be 39 days (SD = 54); further-
more, most SSI-CRANs were detected in the
post-discharge surveillance period, and frequently re-
quired hospital readmission. If the follow up was for 30
days the SSI-CRAN rate would be 58 episodes (9,7%), al-
most half of these episodes would have been lost. These
findings concur with the results of other studies [5, 6] sug-
gesting that limiting follow-up to 30-days would cause
several cases to be missed. In our view, the CDC scoring
system should be used, but with a minimum follow-up
time of 3 months (See Additional file 2).
The most common reasons for surgery in our study
were tumour (intrinsic and extrinsic) and vascular con-
ditions. Rates of SSI-CRAN following extrinsic tumours
surgery were significantly higher than following other
surgeries: extrinsic tumours require a more aggressive
approach and are often associated with difficulties in
haemostasis and closure. Interestingly, there was no rela-
tion between SSI-CRAN and epilepsy. As most of the
few studies on the subject [22–24] are case reports or
have a small sample size, more evidence is still needed.
To the best of our knowledge, this is the first study
evaluating SSI-CRAN aetiologies according to surgical
site. The most frequently isolated microorganisms were
Gram-positive cocci, as seen in many previous studies
[2, 4, 5, 7, 8, 17]. C. acnes has frequently been identified
as a cause of delayed SSI-CRAN [25]. These findings
lend support to our proposal to extend post-discharge
surveillance to a minimum of 3 months post-surgery, in
order to avoid loss of cases. Interestingly, we found a
higher rate of SSI-CRAN caused by E. cloacae than
other studies [2, 4, 5, 7, 8, 17]. It should be noted that E.
cloacae is resistant to cefuroxime, the prophylactic anti-
biotic used at our institution; this microorganism is able
to thrive in humid environments, including water and
soil and particularly in healthcare settings. Future studies
should investigate care bundle interventions that could
prevent Gram-negative SSI-CRANs.
We did not find any relationship between age, gender,
emergency procedures, antibiotic prophylaxis, surgical
site and duration of surgery. Likewise, and in agreement
with other studies [4, 26–29], the NNIS index was not
associated with the SSI-CRAN occurrence. [30]. This
score is useful in predicting the acquisition of surgical
site infection in other procedures but not for cranioto-
mies, probably because most procedures are clean and
the duration of surgery does not vary greatly according
to reason for surgery. In our study, immunosuppression
was not associated with SSI-CRAN. Previous studies
have reported conflicting results: some researchers
found an association between prolonged use of steroids
or chemotherapy with the risk of surgical site infection
[6, 31], but others did not [32].
We found that the only independent risk factors for
SSI-CRAN were ASA score > 2 and re-intervention. Both
variables are well known risk factors for other sites of surgi-
cal infection [32–36] and were also identified in previous
studies analysing risk factors for SSI-CRAN [1, 4]. The
ASA score includes patients’ baseline status, taking into ac-
count their comorbidities. In agreement with previous stud-
ies [1, 4, 33–37], the SSI-CRAN rates were significantly
higher in patients with ASA > 2. Like other researchers [1,
38, 39], we found that patients with re-intervention had an
increased risk for infection; therefore, more attention
should be paid to patients with the above mentioned risk
factors, hardly modifiable by neurosurgeons in most cases.
The strengths of this study are the large number of pa-
tients included and the prospective data collection proced-
ure using an internationally accepted definition of surgical
site infection and a well-defined follow-up period accord-
ing to the guidelines [14], which allows reliable compari-
sons of our results. The fact that a well-trained infection
control team oversaw the surveillance programme was an-
other strength. However, there are certain limitations that
should be acknowledged. For example, the study was con-
ducted at a single centre, and our findings need to be vali-
dated by other studies. Nevertheless, our neurosurgery
department is a reference centre in Catalonia and serves a
population of over 1,500,000 inhabitants.
Conclusion
The risk factors and causative agents of SSI-CRAN identi-
fied here should be considered when designing preventive
strategies aimed to reduce the incidence of this serious
complication.
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